The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin

PJ Hesketh; SM Grundberg; RJ Gralla; DG Warr; F Roila; Ronald de Wit; SP Chawla; AD Carides; J Ianus; ME Elmer; JK Evans; K Beck; S Reines; KJ Horgan

The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin

PJ Hesketh, SM Grundberg, RJ Gralla, DG Warr, F Roila, Ronald de Wit, SP Chawla, AD Carides, J Ianus, ME Elmer, JK Evans, K Beck, S Reines, KJ Horgan

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	4112-4119
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	21
Publication status	Published - 2003

Research programs

EMC MM-03-86-08
EMC OR-01-86-13

Cite this

Hesketh, PJ., Grundberg, SM., Gralla, RJ., Warr, DG., Roila, F., de Wit, R., Chawla, SP., Carides, AD., Ianus, J., Elmer, ME., Evans, JK., Beck, K., Reines, S., & Horgan, KJ. (2003). The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin. Journal of Clinical Oncology, 21, 4112-4119.

@article{2d4960788883403bbe50e395f783aa85,

title = "The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin",

author = "PJ Hesketh and SM Grundberg and RJ Gralla and DG Warr and F Roila and {de Wit}, Ronald and SP Chawla and AD Carides and J Ianus and ME Elmer and JK Evans and K Beck and S Reines and KJ Horgan",

year = "2003",

language = "Undefined/Unknown",

volume = "21",

pages = "4112--4119",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

}

Hesketh, PJ, Grundberg, SM, Gralla, RJ, Warr, DG, Roila, F, de Wit, R, Chawla, SP, Carides, AD, Ianus, J, Elmer, ME, Evans, JK, Beck, K, Reines, S & Horgan, KJ 2003, 'The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin', Journal of Clinical Oncology, vol. 21, pp. 4112-4119.

The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin. / Hesketh, PJ; Grundberg, SM; Gralla, RJ et al.
In: Journal of Clinical Oncology, Vol. 21, 2003, p. 4112-4119.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: a multinational, randomized, double-blind, placebo controlled trial in patients receiving high-dose cisplatin

AU - Hesketh, PJ

AU - Grundberg, SM

AU - Gralla, RJ

AU - Warr, DG

AU - Roila, F

AU - de Wit, Ronald

AU - Chawla, SP

AU - Carides, AD

AU - Ianus, J

AU - Elmer, ME

AU - Evans, JK

AU - Beck, K

AU - Reines, S

AU - Horgan, KJ

PY - 2003

Y1 - 2003

M3 - Article

SN - 0732-183X

VL - 21

SP - 4112

EP - 4119

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -